dimethicone 10 MG/ML Topical Cream

Known as: Dimethicone 0.4 g in 40 mL TOPICAL CREAM [EASYDEW DAILY DOUBLE HYDRA ESSENCE], DIMETHICONE/OLIVAMINE CREAM,TOP, Dimethicone 0.60 mg in 60 g TOPICAL CREAM [askinDr MOIST MOISTURE] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Conditional gene inactivation using the Cre/loxP system has lead to significant advances in our understanding of the function of… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
DLX1 and DLX2 transcription factors are necessary for forebrain GABAergic neuron differentiation, migration, and survival. We… (More)
Is this relevant?
2007
2007
Cre recombinase is extensively used to engineer the genome of experimental animals. However, its usefulness is still limited by… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2006
2006
Dopamine-activated signaling regulates locomotor and emotional responses and alterations in dopamine-signaling are responsible of… (More)
Is this relevant?
2005
2005
We report a knock-in mouse expressing Cre recombinase from the translational initiation site (ATG) of the endogenous L7/Pcp-2… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Prostate-specific gene ablation provides a powerful tool for functional characterization of genes that have impact on… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Effective use of conditional Cre recombinase-loxP gene modification requires Cre-expressing mouse strains with defined patterns… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1991
1991
CRE-BP1 is a transcriptional regulator binding to the cyclic AMP response element (CRE). To understand the role of CRE-BP1 in… (More)
Is this relevant?
1990
1990
The proto-oncogene products Fos and Jun form a stable heterodimeric complex that functions in transcriptional regulation by… (More)
Is this relevant?